Will Abivax's share price close above its pre-announcement level of $11.50 (USD) by July 1, 2027?

Abivax's stock price dropped significantly after a clinical trial update for its bowel disease drug. This question assesses whether the company can recover its market value within the next few months, indicating a potential rebound in investor confidence.

Implied probability (Yes)

20%

Closes

2029-08-31